Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'
Kimberly-Clark CEO Mike Hsu discussed his company's $48.7 billion acquisition of Kenvue in a Monday interview with CNBC's Jim Cramer.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
since
auto-detected in 17 stories
33 days ago
34 days ago
75 days ago
found
a story from Financial Times ✅ › Financial Times